Organization · Venture Capital
KVARKO
KVARKO is a venture capital firm based in Wrocław, Poland, focused on investing in early-stage scientific and technology companies. The firm emphasizes supporting innovations with strong intellectual property and scalable business models.
Overview
What KVARKO does
What KVARKO is
KVARKO is a venture capital firm based in Wrocław, Poland, focused on investing in early-stage scientific and technology companies. The firm emphasizes supporting innovations with strong intellectual property and scalable business models.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find KVARKO elsewhere
Open the official website or a supported primary organization account.
Capability profile
KVARKO as a funder
Investment thesis
KVARKO aims to help science come to life by backing breakthrough thinkers and future-shaping ideas, focusing on early-stage scientific and technology companies with unique technologies and strong intellectual property.
Focus narrative
KVARKO invests primarily in early-stage companies, particularly in technology and biotechnology. Their investment thesis focuses on supporting founders who are turning complex science into technological breakthroughs, especially in sectors such as agri-food bioeconomy, environmental technologies, and veterinary medicine.
Value beyond capital
KVARKO adds value to its portfolio companies by providing not only capital but also long-term operational support, helping founders navigate the complexities of building their businesses and bringing scientific innovations to market.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Notable portfolio companies include: QNA Technology: Develops colloidal semiconductor quantum dots for light emission and absorption applications. SatRevolution: Aims to capture high-resolution Earth imagery through a constellation of nanosatellites. Bioceltix: Innovates veterinary therapies through biopharmaceuticals based on stem cells. Farm Innovations: Builds intelligent herd management systems for modernizing farms. Biovetika: Develops next-generation veterinary vaccines targeting Gram-negative bacteria. DEBN: Creates a novel prostate biopsy needle for urologists.
Common questions
What to know about KVARKO
Upseed classifies KVARKO under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.